Methylthioribose-1-Phosphate Isomerase 1 (Mri1) (N-Term) Peptide
Quick Overview for Methylthioribose-1-Phosphate Isomerase 1 (Mri1) (N-Term) Peptide (ABIN8105310)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- MGC3207 Peptide - N-terminal region
-
Sequence
- VNMARAARDL ADVAAREAER EGATEEAVRE RRETELCEHW EEHTRQRELP
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-MGC3207 Antibody (ARP60474_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- MRI1 (Mri1) (Methylthioribose-1-Phosphate Isomerase 1 (Mri1))
-
Background
-
Background Information: MGC3207 catalyzes the interconversion of methylthioribose-1-phosphate (MTR-1-P) into methylthioribulose-1-phosphate (MTRu-1-P). Independently from catalytic activity, MGC3207 promotes cell invasion in response to constitutive RhoA activation by promoting FAK tyrosine phosphorylation and stress fiber turnover.
Alternative Symbols: MGC3207, MTNA, Ypr118w
-
Molecular Weight
- 34kDa
-
Gene ID
- 84245
-
NCBI Accession
- NP_115661
-
UniProt
- Q9BV20
Target
-